AKAP4 and breast cancer: In contrast, AKAP4 showed expression at the gene and protein level in majority of breast cancer patients (85%) irrespective of histotypes, stages and clinical grades of breast cancer, suggestive of its potential as a biomarker and therapeutic candidate.